Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Apr 3, 2025 · 10-K · 93 days after period end · 0001641172-25-002614
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$512.27K | -$1.28M | -$754.56K | -$998.40K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Apr 3, 2025 · 93 d after period end
